Spero Therapeutics Inc (SPRO) Stock is looking to regain its victory

Evercore ISI raised the price target for the Spero Therapeutics Inc (NASDAQ:SPRO) stock from “an In-line” to “an Outperform”. The rating was released on September 23, 2022, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $40. The stock was initiated by Berenberg, […]